Clinical Trial Update: Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating telmisartan to reduce fibrotic and inflammatory contributors in HIV-1 infection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-04-12